[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_5678 

# __Rapid mutation of microorganisms and adaptation as a cause of human diseases__

## Articles mentionning the risk

* [Bolashikov_methods_2009](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_417.md)

## Mitigations of this risk

* [Development of broad-spectrum antiviral drugs, global surveillance networks, and vaccine research](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_7551.md)

## Name of the risk

Potential for vaccine evasion, drug resistance, and increased transmission rates

## People affected by this risk

* [Global population](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_278.md)

## Stakeholders who can mitigate this risk

* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)

## Technologies linked to the risk

* [And international collaboration platforms](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_2336.md)
* [Big data analytics](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6931.md)
* [Crispr technology](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_6932.md)

## This Risk belongs to this RiskGroup

* [Technological risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_8.md)

## This Risk belongs to this RiskSubgroup

* [Healthcare and medical risks](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_15.md)

